To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 11,980 shares, the number of shares held increased 2.57% compared to the previous period and now represents 3.9% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 41,680 shares, the number of shares held increased 2.57% compared to the previous period and now represents 2.34% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 266,200 shares, the number of shares held increased 2.57% compared to the previous period and now represents 1.42% of the total position.
      6.54K3
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 50,160 shares, the number of shares held increased 2.57% compared to the previous period and now represents 8.54% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 53,700 shares, the number of shares held increased 2.57% compared to the previous period and now represents 5.17% of the total position.
      130Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 119,120 shares, the number of shares held increased 2.57% compared to the previous period and now represents 1.63% of the total position.
      17Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 127,000 shares, the number of shares held increased 2.57% compared to the previous period and now represents 2.04% of the total position.
      32Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 8,680 shares, the number of shares held increased 2.57% compared to the previous period and now represents 2.4% of the total position.
      22Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 12,160 shares, the number of shares held increased 2.57% compared to the previous period and now represents 0.58% of the total position.
      172Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 50,620 shares, the number of shares held increased 2.57% compared to the previous period and now represents 2.3% of the total position.
      38Comment
      Report
       
       
       
       

      Most Discussed